[HTML][HTML] Metabolomic characterization reveals ILF2 and ILF3 affected metabolic adaptions in esophageal squamous cell carcinoma
B Zang, W Wang, Y Wang, P Li, T Xia, X Liu… - Frontiers in Molecular …, 2021 - frontiersin.org
Esophageal cancer (EC) is a common malignant disease in eastern countries. However, a
study of the metabolomic characteristics associated with other biological factors in …
study of the metabolomic characteristics associated with other biological factors in …
Proteomic and metabolic signatures of esophageal squamous cell carcinoma
K Karagoz, HL Lehman, DB Stairs… - Current cancer drug …, 2016 - ingentaconnect.com
Esophageal squamous cell carcinoma (ESCC), which is the most common subtype of
esophageal cancers, is the sixth leading cause of cancer deaths worldwide with a five-year …
esophageal cancers, is the sixth leading cause of cancer deaths worldwide with a five-year …
[HTML][HTML] Untargeted metabolomics analysis of esophageal squamous cell carcinoma discovers dysregulated metabolic pathways and potential diagnostic biomarkers
ZJ Zhu, Z Qi, J Zhang, WH Xue, LF Li, ZB Shen… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most fatal
diseases worldwide. Because early diagnosis is difficult, ESCC is mostly diagnosed at an …
diseases worldwide. Because early diagnosis is difficult, ESCC is mostly diagnosed at an …
[HTML][HTML] Combined metabolomic analysis of plasma and tissue reveals a prognostic risk score system and metabolic dysregulation in esophageal squamous cell …
Z Chen, Y Dai, X Huang, K Chen, Y Gao, N Li… - Frontiers in …, 2020 - frontiersin.org
Background: Esophageal squamous cell carcinoma (ESCC) is a gastrointestinal malignancy
with a poor prognosis. Although studies have shown metabolic reprogramming to be linked …
with a poor prognosis. Although studies have shown metabolic reprogramming to be linked …
[HTML][HTML] Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma
J Cheng, Q Liu, H Jin, D Zeng, Y Liao, Y Zhao… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract Background Esophageal Squamous Cell Carcinoma (ESCC) is an aggressive
malignancy, leading to more than 250,000 deaths in China every year. However, the …
malignancy, leading to more than 250,000 deaths in China every year. However, the …
Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma
Z Chen, Y Gao, X Huang, Y Yao, K Chen… - … of Pharmaceutical and …, 2021 - Elsevier
Prognosis for esophageal squamous cell carcinoma (ESCC) is poor, so it is essential to
develop a more complete understanding of the disease. The purpose of this study was to …
develop a more complete understanding of the disease. The purpose of this study was to …
[HTML][HTML] Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers
J Xu, Y Chen, R Zhang, Y Song, J Cao, N Bi… - Molecular & Cellular …, 2013 - ASBMB
Diagnostic and therapeutic biomarkers useful for esophageal squamous cell carcinoma
(ESCC) have the ability to increase the long term survival of cancer patients. A …
(ESCC) have the ability to increase the long term survival of cancer patients. A …
LC–MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers with
poor prognosis. Here, we carried out liquid chromatography–quadrupole time-of-flight mass …
poor prognosis. Here, we carried out liquid chromatography–quadrupole time-of-flight mass …
[HTML][HTML] Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
J Xu, Y Chen, R Zhang, J He, Y Song, J Wang… - Scientific Reports, 2016 - nature.com
We performed a metabolomics study using liquid chromatography-mass spectrometry (LC-
MS) combined with multivariate data analysis (MVDA) to discriminate global urine profiles in …
MS) combined with multivariate data analysis (MVDA) to discriminate global urine profiles in …
Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform
H Zhang, L Wang, Z Hou, H Ma, B Mamtimin… - Biochemical and …, 2017 - Elsevier
Esophageal cancer (EC) is one of the most common malignancies with poor prognosis.
Metabolomics has been shown to be a powerful approach to discover the potential …
Metabolomics has been shown to be a powerful approach to discover the potential …